IN BRIEF: 4D Pharma shares cancelled from trading on London's AIM
4D Pharma PLC - Leeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administration in June 2022. Read More
DDDD.L (DDDD) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|
DDDD.L (DDDD) Regulatory News |
||
Date | Source | Headline |
---|---|---|
16th Feb 2023 7:00 am | RNS | Cancellation - 4d Pharma Plc |
15th Feb 2023 1:16 pm | RNS | Cancellation of admission to trading on AIM |
2nd Feb 2023 3:10 pm | RNS | Updated Results from Renal Cell Carcinoma Cohort |
16th Jan 2023 10:15 am | RNS | Result of Meeting |
30th Dec 2022 12:30 pm | RNS | Update on Administration and Suspension of Trading |
16th Nov 2022 7:00 am | RNS | Blautix Phase II Clinical Trial Results Published |
10th Nov 2022 2:00 pm | RNS | MRx0518 SITC 2022 poster presentations |
5th Oct 2022 1:00 pm | RNS | MRx0518 poster presentations at SITC 2022 |
29th Sep 2022 10:00 am | RNS | Update on Suspension of Trading on AIM |
24th Aug 2022 7:00 am | RNS | Publication of preclinical autism research |